Developing a first-in-class therapy for GRIN-NDD Radiprodil is in development as the first therapy designed to directly address the underlying biology of GRIN-related neurodevelopmental disorder.

https://www.drugdiscoverynews.com/developing-a-first-in-class-therapy-for-grin-ndd-16784